Project 1 - Genetics of male infertility in the Collaborative Cross resource
- Institution
- UNIV OF NORTH CAROLINA CHAPEL HILL, NC
- Principal investigator
- Fernando Pardo-Manuel De Villena
- Funding
- $500K
- Duration
- 1999–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY: Project 1 The Collaborative Cross (CC) is a popular system genetics platform to study biomedical traits and as a rich source of optimized models of human disease. The CC is an integral part of the MMRRC at UNC and represents over 85% of live mice distributed by our center. During the inbreeding phase of the CC project, 95% of the CC lines became extinct in large part due to male infertility. Even after the major wave of extinction, the extant CC lines remain a challenging population to breed. Since 2019 the continued success of the CC as a platform has been predicated on maintaining a stable set of 63 CC strains readily available for the community. In other words, strains that are most challenging to breed and are also the most expensive to maintain live in the shelf, are critical for the project. A subset of the most challenging strains are characterized by high incidence of male infertility, with incidence approaching 50% in the following four CC strains: CC031/GeniUnc, CC065/Unc, CC072/TauUnc and CC075/Unc. Here we propose to use genetic analysis to identify, and eliminate or reduce the impact of male infertility in the four CC strains with the highest incidence of male infertility.
LOADING MOONBASE SCORE
Questions for UNIV OF NORTH CAROLINA CHAPEL HILL
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Univ of North Carolina Chapel HillNot yet scored
Preconception iAs exposure: diabetes and epigenetic inheritance
Fernando Pardo-Manuel De Villena · $513K · 2020–2030
- NIH · Univ of North Carolina Chapel Hill65
Cortical circuits for the integration of parallel short-latency auditory pathways
Hiroyuki Kato · $469K · 2022–2027
- NIH · Univ of North Carolina Chapel Hill47
Study to establish safety, tolerability and feasibility of LM11A-31 as a neuroprotective agent in aging people living with HIV and neurocognitive impairment on antiretroviral therapy
Rick B Meeker · $638K · 2023–2029